EcoDrugPlus

Epoxide Hydrolase 2, Cytoplasmic

Ensembl ID : ENSOMYG00000014450
Gene Symbol: EPHX2
2 Cross references
197 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSOMYG00000042476
Gene Symbol: ERBB2
2 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSOMYG00000008377
Gene Symbol: ERBB3
1 Cross references
205 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSOMYG00000024129
Gene Symbol: ERBB3B
1 Cross references
199 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSOMYG00000013780
Gene Symbol: ERBB3B
1 Cross references
199 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOMYG00000022267
Gene Symbol: ERBB4
1 Cross references
8 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOMYG00000012021
Gene Symbol: ERBB4
1 Cross references
228 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOMYG00000021728
Gene Symbol: ERBB4
1 Cross references
9 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOMYG00000019366
Gene Symbol: ESR1
2 Cross references
207 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSOMYG00000011232
Gene Symbol: ESR2A
2 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta 2

Ensembl ID : ENSOMYG00000031569
Gene Symbol: ERB2
2 Cross references
203 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSOMYG00000015253
Gene Symbol: ESRRGA
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).